These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 19835716)
1. Extended regimens of the vaginal contraceptive ring: cycle control. Guazzelli CA; Barreiros FA; Barbosa R; de Araújo FF; Moron AF Contraception; 2009 Nov; 80(5):430-5. PubMed ID: 19835716 [TBL] [Abstract][Full Text] [Related]
2. Bleeding patterns of women using extended regimens of the contraceptive vaginal ring. Barreiros FA; Guazzelli CA; de Araújo FF; Barbosa R Contraception; 2007 Mar; 75(3):204-8. PubMed ID: 17303490 [TBL] [Abstract][Full Text] [Related]
3. Extended regimens of the contraceptive vaginal ring versus hormonal oral contraceptives: effects on lipid metabolism. Guazzelli CA; Barreiros FA; Barbosa R; Torloni MR; Barbieri M Contraception; 2012 Apr; 85(4):389-93. PubMed ID: 22067754 [TBL] [Abstract][Full Text] [Related]
4. Extended regimens of the contraceptive vaginal ring: evaluation of clinical aspects. Barreiros FA; Guazzelli CA; Barbosa R; de Assis F; de Araújo FF Contraception; 2010 Mar; 81(3):223-5. PubMed ID: 20159178 [TBL] [Abstract][Full Text] [Related]
5. Extended regimens of the combined contraceptive vaginal ring containing etonogestrel and ethinyl estradiol: effects on lipid metabolism. Barreiros FA; Guazzelli CA; Barbosa R; Torloni MR; Barbieri M; Araujo FF Contraception; 2011 Aug; 84(2):155-9. PubMed ID: 21757057 [TBL] [Abstract][Full Text] [Related]
6. Bleeding pattern with drospirenone 3 mg+ethinyl estradiol 20 mcg 24/4 combined oral contraceptive compared with desogestrel 150 mcg+ethinyl estradiol 20 mcg 21/7 combined oral contraceptive. Anttila L; Kunz M; Marr J Contraception; 2009 Nov; 80(5):445-51. PubMed ID: 19835718 [TBL] [Abstract][Full Text] [Related]
8. Cycle control and side effects of a new combiphasic oral contraceptive regimen. Dieben TO; op ten Berg MT; Coelingh Bennink HJ Arzneimittelforschung; 1994 Jul; 44(7):877-9. PubMed ID: 7945527 [TBL] [Abstract][Full Text] [Related]
9. Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive. Westhoff C; Osborne LM; Schafer JE; Morroni C Obstet Gynecol; 2005 Jul; 106(1):89-96. PubMed ID: 15994622 [TBL] [Abstract][Full Text] [Related]
10. Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen. Weisberg E; Merki-Feld GS; McGeechan K; Fraser IS Contraception; 2015 Feb; 91(2):121-6. PubMed ID: 25459098 [TBL] [Abstract][Full Text] [Related]
11. Extended regimens of the contraceptive vaginal ring: a randomized trial. Miller L; Verhoeven CH; Hout Ji Obstet Gynecol; 2005 Sep; 106(3):473-82. PubMed ID: 16135576 [TBL] [Abstract][Full Text] [Related]
12. Lower hormone dosage with improved cycle control. Vree M Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 2():25-30; discussion 37-9. PubMed ID: 12659399 [TBL] [Abstract][Full Text] [Related]
13. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel. Ahrendt HJ; Makalová D; Parke S; Mellinger U; Mansour D Contraception; 2009 Nov; 80(5):436-44. PubMed ID: 19835717 [TBL] [Abstract][Full Text] [Related]
14. A large observational clinical evaluation of a desogestrel-containing combiphasic oral contraceptive in Germany. Vree ML; Schmidt J Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):108-14. PubMed ID: 11518448 [TBL] [Abstract][Full Text] [Related]
15. Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen. Weisberg E; Brache V; Alvarez F; Massai R; Mishell DR; Apter D; Gale J; Sivin I; Tsong YY; Fraser IS Contraception; 2005 Jul; 72(1):46-52. PubMed ID: 15964292 [TBL] [Abstract][Full Text] [Related]
17. Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial. Sulak PJ; Smith V; Coffee A; Witt I; Kuehl AL; Kuehl TJ Obstet Gynecol; 2008 Sep; 112(3):563-71. PubMed ID: 18757653 [TBL] [Abstract][Full Text] [Related]
18. Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study. Cagnacci A; Ferrari S; Tirelli A; Zanin R; Volpe A Contraception; 2009 Jul; 80(1):34-9. PubMed ID: 19501213 [TBL] [Abstract][Full Text] [Related]
19. An open-label, multicentre trial to evaluate the vaginal bleeding pattern of the combined contraceptive vaginal ring NuvaRing. Bruni V; Pontello V; Luisi S; Petraglia F Eur J Obstet Gynecol Reprod Biol; 2008 Jul; 139(1):65-71. PubMed ID: 18358586 [TBL] [Abstract][Full Text] [Related]
20. Ethinylestradiol + etonogestrel contraceptive vaginal ring: new drug. Possibly useful in some situations. Prescrire Int; 2006 Apr; 15(82):50-3. PubMed ID: 16604729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]